FKBP5 rs4713915: Stress Reactivity and Genetic Variation
The rs4713915 single nucleotide polymorphism is an intronic regulatory variant within the FKBP5 gene. Scientific research links this variant to changes in glucocorticoid receptor sensitivity and physiological reactivity to acute psychological stressors. However, overall clinical evidence remains limited and is characterized by modest statistical associations rather than direct medical outcomes.
What each genotype means
Typical stress response
You carry two copies of the common G allele for this FKBP5 variant. Research indicates this genotype is associated with baseline glucocorticoid receptor feedback regulation and typical hormonal recovery after acute stress. Evidence for rs4713915 specifically remains limited and does not represent a medical diagnosis.
Carried by approximately 40% to 45% of individuals globally, being most frequent in populations of African and East Asian ancestry.
Moderately altered stress reactivity
You carry one copy of the A regulatory allele associated with altered FKBP5 expression and modest differences in cortisol receptor sensitivity. In scientific literature, carrying one minor allele in FKBP5 regulatory regions is linked to mild differences in stress recovery dynamics, though clinical evidence remains limited and context-dependent. This profile is not diagnostic of any health condition or disorder.
Carried by approximately 40% to 45% of people across diverse global populations.
Heightened stress reactivity
You carry two copies of the A allele, which has been studied for its potential influence on glucocorticoid receptor complex reactivity and hypothalamic-pituitary-adrenal axis regulation. While some studies connect regulatory FKBP5 variants with prolonged or heightened physiological responses to stress, findings specifically evaluating rs4713915 are limited and heavily influenced by environmental factors. These findings do not indicate any disease state or clinical impairment.
Carried by roughly 10% to 15% of individuals worldwide, with frequency varying across ancestral groups.
Genomic Location and Variant Characteristics
The single nucleotide polymorphism rs4713915 is situated within an intronic region of the FKBP5 gene on chromosome 6. Rather than altering an amino acid sequence directly, this variant is localized in an intronic enhancer element. Genetic variants in non-coding regulatory sequences often exert their influence by altering chromatin structure, binding affinity for transcription factors, or baseline transcriptional efficiency. In the case of rs4713915, the variation involves an exchange between guanine (G) and adenine (A) alleles. Because intronic enhancers modulate how genes respond to upstream cellular and endocrine signaling pathways, rs4713915 is classified as a regulatory variant. While it does not disrupt the primary protein sequence, researchers investigate its potential to alter the rate of gene transcription in response to glucocorticoid signaling cascades.
The Biological Role of FKBP5 in Stress Physiology
The FKBP5 gene encodes the FK506-binding protein 51, a molecular co-chaperone that interacts directly with heat shock protein 90 (Hsp90) and the glucocorticoid receptor (GR). When cortisol or other glucocorticoids bind to the GR, the receptor translocates to the nucleus to regulate target gene expression and orchestrate the termination of the physiological stress response through negative feedback. FKBP5 functions as an ultrashort negative feedback loop: it binds the glucocorticoid receptor complex, reducing its affinity for cortisol and hindering nuclear translocation. Increased cellular concentrations of FKBP5 lead to reduced glucocorticoid receptor sensitivity, whereas lower levels allow faster receptor activation. Through this mechanism, FKBP5 plays a pivotal role in fine-tuning hypothalamic-pituitary-adrenal (HPA) axis dynamics during and following environmental stress.
Research Associations and Evidence Evaluation
Academic literature examining FKBP5 polymorphisms has focused on how subtle regulatory variations affect human stress reactivity, cortisol recovery dynamics, and susceptibility to affective disorders. Polymorphisms across the FKBP5 locus, including rs4713915, have been evaluated in observational cohorts assessing hypothalamic-pituitary-adrenal axis reactivity during standardized laboratory stress tasks. Some candidate gene studies suggest that minor allele carriers may demonstrate altered glucocorticoid receptor sensitivity or prolonged cortisol clearance times under acute stress. Nevertheless, the clinical evidence for rs4713915 specifically remains categorized as limited. Large-scale genome-wide association studies (GWAS) often demonstrate mixed findings or fail to reach genome-wide significance for diagnostic psychiatric endpoints, indicating that individual effect sizes are small and heavily modulated by environmental factors and broader polygenic architecture.
Population Distribution and Genotype Patterns
The rs4713915 variant is common across diverse human populations. According to reference data from large aggregation resources such as gnomAD and dbSNP, the minor A allele occurs at an estimated global frequency of approximately 0.35. The major G allele accounts for the remaining 0.65 of observed alleles globally. Consequently, all three standard diploid genotypes—homozygous GG, heterozygous AG, and homozygous AA—are widely represented in the general population. While slight frequency variations exist across continental ancestries, the widespread prevalence of the minor allele underscores that carrying an A allele is a standard human variation rather than a rare or deleterious mutation. Its common status in healthy population cohorts further reinforces that the variant confers subtle physiological shifts rather than deterministic clinical phenotypes.
Contextualizing Genetic Information for Personal Health
Understanding your rs4713915 genotype provides an educational glimpse into the biology of stress-related neuroendocrine pathways, but it cannot be used to diagnose, predict, or treat any medical or psychiatric condition. Stress reactivity is an exceedingly complex polygenic trait shaped by hundreds of genetic variants interacting with childhood history, life experiences, lifestyle habits, and social support. No direct medical interventions or medication changes are warranted based on an individual's rs4713915 genotype. If you are taking prescription medications, such as glucocorticoids or psychiatric pharmacotherapies, any questions regarding efficacy, side effects, or dosing must be discussed directly with a qualified physician or clinical pharmacist rather than inferred from single nucleotide polymorphisms.
How common is this variant?
The minor A allele has a global frequency of approximately 0.35 in gnomAD reference populations, with the remaining 0.65 represented by the common G allele. Consequently, heterozygous (AG) and homozygous (GG and AA) genotypes are widely distributed and frequently observed worldwide.
Frequently asked questions
Can rs4713915 predict if I will develop anxiety or depression?
No. The rs4713915 polymorphism has only limited statistical associations with physiological stress reactivity in research settings. Mental health conditions are multifactorial, driven by polygenic networks and environmental factors, making single genetic variants ineffective for predicting diagnostic outcomes.
How does FKBP5 affect the body's stress hormone response?
The FKBP5 gene produces a co-chaperone protein that binds to the glucocorticoid receptor, temporarily reducing its ability to respond to cortisol. This system serves as a molecular brake that helps coordinate the activation and shutdown of the body's stress response.
Does carrying the rs4713915 A allele mean I have chronic stress?
No. Carrying the A allele is a common biological variation found in roughly a third of chromosomes worldwide. It does not mean you have elevated stress levels, nor does it guarantee a heightened biological response to life events.
Should I alter my medication or cortisol treatment based on this result?
You should never adjust any medication or treatment regimen based on individual SNP results. Any decisions involving steroid therapies, antidepressants, or other prescription drugs must be evaluated in consultation with your prescribing clinician or a pharmacist.
Sources & further reading
Educational information only, last refreshed 9/12/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs4713915?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29Related variants in FKBP5
This intronic variant in the FKBP5 gene modulates glucocorticoid receptor sensitivity and is linked to altered stress reactivity and susceptibility to psychiatric conditions like PTSD and depression.
Intronic variant in FKBP5; while FKBP5 is a well-established stress-response gene, specific associations for rs4713919 with HPA axis dynamics are less robustly replicated than other variants like rs1360780.
Modulates FKBP5 chaperone expression and alters glucocorticoid receptor sensitivity and negative feedback regulation of the HPA axis.
Regulatory variant in FKBP5 affecting glucocorticoid receptor chaperone activity and susceptibility to stress-related neuropsychiatric outcomes.
Intronic regulatory variant within FKBP5 linked to altered glucocorticoid receptor sensitivity and acute cortisol response following psychosocial stress.
Functional polymorphism in FKBP5 that modulates ultradian and stress-induced cortisol secretion and alters recovery trajectories following acute psychological stress.